PI3K-AKT-mTOR signaling in prostate cancer progression and androgen deprivation therapy resistance

Prostate cancer (PCa) is the second most common malignancy among men in the world. Castration-resistant prostate cancer (CRPC) is the lethal form of the disease, which develops upon resistance to first line androgen deprivation therapy (ADT). Emerging evidence demonstrates a key role for the PI3K-AK...

Descripción completa

Detalles Bibliográficos
Autores principales: Edlind, Merritt P, Hsieh, Andrew C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Invited Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4023363/
https://www.ncbi.nlm.nih.gov/pubmed/24759575
http://dx.doi.org/10.4103/1008-682X.122876

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4023363/
https://www.ncbi.nlm.nih.gov/pubmed/24759575
http://dx.doi.org/10.4103/1008-682X.122876

Ejemplares similares